Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI

This study has been completed.
Sponsor:
Collaborators:
Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena
Ospedale "Perrino" Brindisi
A.O. B.M.M., Reggio Calabria
Azienda Ospedaliera Villa Sofia
Azienda Ospedaliera V. Cervello
Università di Ferrara
Second University of Naples
Information provided by:
Ente Ospedaliero Ospedali Galliera
ClinicalTrials.gov Identifier:
NCT01140321
First received: June 7, 2010
Last updated: June 8, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
No publications provided by Ente Ospedaliero Ospedali Galliera

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):